Avenue Therapeutics, Inc. acquired Baergic Bio, Inc. in a deal involving two pharmaceutical companies. Terms of the transaction were not disclosed.
Founded in December 2019, Baergic Bio is a clinical-stage company that focuses on the development of a pharmaceutical product for the treatment of neurological disorders.
Avenue Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of central nervous system diseases. It is owned by Fortress Biotech, Inc.
According to the LevinPro HC database, this was the 86th pharmaceutical deal of 2022. This compares with 42 pharmaceutical transactions that were reported between January 1, 2021, and November 10, 2021.
